US2145214A - Parasiticide - Google Patents

Parasiticide Download PDF

Info

Publication number
US2145214A
US2145214A US2145214DA US2145214A US 2145214 A US2145214 A US 2145214A US 2145214D A US2145214D A US 2145214DA US 2145214 A US2145214 A US 2145214A
Authority
US
United States
Prior art keywords
guanidine
salt
mothproofing
composition containing
dixylyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US2145214A publication Critical patent/US2145214A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)

Definitions

  • This invention relates to a composition for treating fibrous materials such as wool against attack by moths and constitutes an improvement upon the subject matter of U. S. Patent 1,915,922. y
  • a suitable solvent such as a petroleum fraction and specifically naphtha.
  • the wool or other fibrous material to be protected is then treated with this solution, and the solvent permitted to evaporate.
  • the fibrous material has a greasy appearance or is greasy to the touch. This is due to the fact that the guanidine is used as a fatty acid salt.
  • the principal object of the present invention is to take advantage of the mothproofing qualities of the di-substituted guanidines using, however, salts thereof which are not subject to the above objection but which, at the same time, are as good or better for the purpose specified.
  • the phenolic salts of the di-substituted guanidines are particularly effective as mothproofing agents. Any di-substituted guanidine may be used as the base for the composition and particularly the diaryl compounds. Dixylyl guanidine is preferred.
  • Any of the hydroxy aryl salts of the di-substituted guanidines may be used for this purpose or the hydroxy alkyl aryl salts thereof.
  • a para tertiary alkyl phenolic salt such as the para tertiary amyl phenolic salt of 40 dimlyl guanidine because ofqtheir greater efllciency.
  • Whichever salt is used it is preferred to dissolve this material in a petroleum fraction such as naphtha or other solvent which may be readily evaporated.
  • a mothproofing composition containing a phenolic salt of a diaryl guanidine containing a phenolic salt of a diaryl guanidine.
  • a mothproofing composition containing hydroxy aryl salt of a diaryl guanidine 4.
  • a mothproofing composition containing a para tertiary alkyl phenolic salt of a diaryl guan- 3o idine containing a para tertiary alkyl phenolic salt of a diaryl guan- 3o idine.
  • a mothproofing composition .containing a para tertiary amyl phenolic salt of a diaryl guanidine.
  • I 40 10 A mothproofing composition containing a phenolic salt of a disubstituted guanidine in a volatile solvent.
  • a mothproofing composition containing a para tertiary amyl phenolic salt of dixylyl guani- 45 dine in a volatile solvent containing a para tertiary amyl phenolic salt of dixylyl guani- 45 dine in a volatile solvent.
  • a mothproofing composition containing a para tertiary alkyl phenolic salt of dixylyl guani dine in a volatile solvent containing a para tertiary alkyl phenolic salt of dixylyl guani dine in a volatile solvent.

Description

Patented Jan. 24, 1939 rmsmcmn David Walker Jayne, Jr., Elizabeth, N. 1., assignor to American Cyanamid Company, New York, N. Y., a corporation of Maine No Drawing. Application March 3, 1936, Serial No. 66,797
12 Claims. (Cl. 16737) This invention relates to a composition for treating fibrous materials such as wool against attack by moths and constitutes an improvement upon the subject matter of U. S. Patent 1,915,922. y In that patent, there has been proposed the treatment of fibrous material for the stated purpose with fatty acid salts of xii-substituted guanidines, specifically dixylyl guanidines. The procedure there proposed is to dissolve such material in a suitable solvent, such as a petroleum fraction and specifically naphtha. The wool or other fibrous material to be protectedis then treated with this solution, and the solvent permitted to evaporate.
When treating fibrous material with. the material of the above patent as above set forth, it.
has been found that in some instances the fibrous material has a greasy appearance or is greasy to the touch. This is due to the fact that the guanidine is used as a fatty acid salt.
The principal object of the present invention, therefore, is to take advantage of the mothproofing qualities of the di-substituted guanidines using, however, salts thereof which are not subject to the above objection but which, at the same time, are as good or better for the purpose specified.
It has been found that the phenolic salts of the di-substituted guanidines are particularly effective as mothproofing agents. Any di-substituted guanidine may be used as the base for the composition and particularly the diaryl compounds. Dixylyl guanidine is preferred.
$ Any of the hydroxy aryl salts of the di-substituted guanidines may be used for this purpose or the hydroxy alkyl aryl salts thereof. I particularly prefer a para tertiary alkyl phenolic salt such as the para tertiary amyl phenolic salt of 40 dimlyl guanidine because ofqtheir greater efllciency. Whichever salt is used, it is preferred to dissolve this material in a petroleum fraction such as naphtha or other solvent which may be readily evaporated.-
As a specific example of preparation of the materlal, three parts of dixylyl guanidine and two parts of para tertiary amyl phenol are mixed together and heated to to C. The mixture is then stirred at this temperatureuntil a clear 50 homogeneous resinous product is obtained. This product is the para tertiary amyl phenol salt of dixylyl guanidine. Ten parts of this material are then dissolved in 8 parts of monobutyl ether of ethylene glycol and this solution diluted with 182 parts of petroleum naphtha to give a solution to be used for mothproofing containing 5% 5 of the guanidine salt. This solution should then be applied to the fibrous material in the proportion of approximately 1 pound of the solution to 20 to 40 pounds of the fibrous material to give desirable mothproofing protection. The solvents 10 are then allowed to evaporate.
While the invention has been shown and described with reference to certain specific embodiments, it is to be understood that the invention is not to be limited thereto but is to be construed l5 broadly and limited only by the scope of the claims.
I claim:
1. A mothproofing composition containing a phenolic salt of a disubstituted guanidine. 20
2. A mothproofing composition containing a phenolic salt of a diaryl guanidine.
3. A mothproofing composition containing a phenolic salt of a dixylyl guanidine.
4. A mothproofing composition containing hydroxy aryl salt of a diaryl guanidine.
5. A mothproofing composition containing a hydroxy alkyl aryl salt of a diaryl guanidine.
6. A mothproofing composition containing a para tertiary alkyl phenolic salt of a diaryl guan- 3o idine.
7. A mothproofing composition .containing a para tertiary amyl phenolic salt of a diaryl guanidine.
8. A mothproofing composition containing a 35 para tertiary alkyl phenolic salt of a dixylyl guanidine.
9. A mothproofing composition containing a para tertiary amyl phenolic salt of dixylyl guanidine. I 40 10. A mothproofing composition containing a phenolic salt of a disubstituted guanidine in a volatile solvent.
11. A mothproofing composition containing a para tertiary amyl phenolic salt of dixylyl guani- 45 dine in a volatile solvent.
12. A mothproofing composition containing a para tertiary alkyl phenolic salt of dixylyl guani dine in a volatile solvent.
navm warm JAYNE, JR.
US2145214D Parasiticide Expired - Lifetime US2145214A (en)

Publications (1)

Publication Number Publication Date
US2145214A true US2145214A (en) 1939-01-24

Family

ID=3429944

Family Applications (1)

Application Number Title Priority Date Filing Date
US2145214D Expired - Lifetime US2145214A (en) Parasiticide

Country Status (1)

Country Link
US (1) US2145214A (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2499226A (en) * 1944-11-23 1950-02-28 American Cyanamid Co Resinous aromatic acid salts of a guanidine as mothproofers
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5403861A (en) * 1991-02-08 1995-04-04 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5574070A (en) * 1990-05-25 1996-11-12 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Substituted guanidines having high binding to the sigma receptor and the use thereof
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5955507A (en) * 1993-11-23 1999-09-21 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6147063A (en) * 1993-05-27 2000-11-14 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6174924B1 (en) 1994-02-03 2001-01-16 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6251948B1 (en) 1990-03-02 2001-06-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2499226A (en) * 1944-11-23 1950-02-28 American Cyanamid Co Resinous aromatic acid salts of a guanidine as mothproofers
US5478863A (en) * 1986-07-10 1995-12-26 State Of Oregon, Oregon Health Sciences University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5312840A (en) * 1986-07-10 1994-05-17 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education Substituted guanidines having high binding to the sigma receptor and the use thereof
US5604228A (en) * 1986-07-10 1997-02-18 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Substituted guanidines having high binding to the sigma receptor and the use thereof
US5385946A (en) * 1986-07-10 1995-01-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Method for treating hypertension with disubstituted granidine compounds
US5502255A (en) * 1986-07-10 1996-03-26 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Substituted guanidines having high binding to the sigma receptor and the use thereof
US5336689A (en) * 1990-03-02 1994-08-09 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US6251948B1 (en) 1990-03-02 2001-06-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5559154A (en) * 1990-03-02 1996-09-24 Oregon State Board Of Higher Education Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5637622A (en) * 1990-03-02 1997-06-10 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5798390A (en) * 1990-03-02 1998-08-25 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5767162A (en) * 1990-03-02 1998-06-16 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5574070A (en) * 1990-05-25 1996-11-12 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Substituted guanidines having high binding to the sigma receptor and the use thereof
US5677348A (en) * 1991-02-08 1997-10-14 Cambridge Neuroscience, Inc. Substituted aminoguanidines and methods of use thereof
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5670519A (en) * 1991-02-08 1997-09-23 Cambridge Neuroscience, Inc. Acenaphthyl-substituted guanidines and methods of use thereof
US5672608A (en) * 1991-02-08 1997-09-30 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5637623A (en) * 1991-02-08 1997-06-10 Cambridge Neuroscience, Inc. Substituted adamantyl guanidines and methods of use there of
US5681861A (en) * 1991-02-08 1997-10-28 Cambridge Neuroscience, Inc. Aminoguanidines and methods of use of same
US5686495A (en) * 1991-02-08 1997-11-11 Cambridge Neuroscience, Inc. Substituted hydrazinedicarboximidamides and methods of use thereof
US6071969A (en) * 1991-02-08 2000-06-06 Cambridge Neuroscience, Inc. Substituted aminoguanidines and methods of use thereof
US5622968A (en) * 1991-02-08 1997-04-22 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5614630A (en) * 1991-02-08 1997-03-25 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5837737A (en) * 1991-02-08 1998-11-17 Cambridge Neuroscience, Inc. Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5403861A (en) * 1991-02-08 1995-04-04 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5652269A (en) * 1991-02-08 1997-07-29 Cambridge Neuroscience, Inc. Substituted hydrazinecarboximidamides and methods of use thereof
US6147063A (en) * 1993-05-27 2000-11-14 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6153604A (en) * 1993-05-27 2000-11-28 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6013675A (en) * 1993-11-23 2000-01-11 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6156741A (en) * 1993-11-23 2000-12-05 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US5955507A (en) * 1993-11-23 1999-09-21 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6174924B1 (en) 1994-02-03 2001-01-16 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6288123B1 (en) 1994-02-03 2001-09-11 Cambridge Neurosciences, Inc. Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US20070265348A1 (en) * 1994-02-03 2007-11-15 Scion Pharmaceuticals, Inc, A Delaware Corporation Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines

Similar Documents

Publication Publication Date Title
US2145214A (en) Parasiticide
US2274476A (en) Insecticide and moth larvae repellent
US2409883A (en) Resinous dibasic carboxylic acid salts of a guanidine as mothproofers
US3647888A (en) Trifluoromethyl-p-nitro diphenyl ethers
US2347688A (en) Rosin and abietic acid salts of a guanidine as a mothproofer
US2539728A (en) Silver salts of disubstituted methane compounds
US2318126A (en) Latex adhesive
US2345036A (en) Mercerizing penetrant
US1853415A (en) Wetting, cleaning and emulsifying agents
US2499226A (en) Resinous aromatic acid salts of a guanidine as mothproofers
US2157854A (en) Composition of matter useful for mothproofing
US1820607A (en) Nonirritating compositions containing organic compounds which irritate the skin
US2106550A (en) 4-aminodiphenyl complex
US1596259A (en) Antiseptic anzesthetic medicament
US2339787A (en) Substituted para-aminobenzene sulphonamide compound
US2213139A (en) Increasing the wetting power of strong alkaline lyes
US615319A (en) Waterproof fabric
US2104290A (en) Treating fibrous materials with alkaline liquids of mercerizing strength
US2035894A (en) Wetting agent
GB446379A (en) Improvements in and relating to methods of producing non-inflammable and non-hygroscopic fibrous material
AT151657B (en) Process for the preparation of formaldehyde sodium sulfoxylates from arsenobenzene compounds.
Lauer et al. Ethers of p-Hydroxybenzoic Acid as Derivatives for the Identification of Alkyl Halides
US1946003A (en) Treatment of latex
DE738310C (en) Firmly forming surface treatment agent
AT224340B (en) Process for stabilizing polymers of ethylenically unsaturated hydrocarbons